Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Oct 07, 2022 1:43pm
114 Views
Post# 35012752

RE:RE:RE:The breadcrumbs I see in the IR

RE:RE:RE:The breadcrumbs I see in the IR

embarassing


daviking wrote: All a bunch of smoke and mirrors, imo!
I'm not sure how to read this latest news. It seems like they are never going to finish this trial and have to keep looking for money. Keep diluting my shares!!!!
There sure is going to be a nice tax loss if and whenever this is taken over or they finally get approved and go on their own (I don't believe for a moment that this Admin and BOD have the wherewithal to do that).
Euphrates trial had 450 patients over 5-in 6 years so 75-90 per year.
Now that the scourge of the pandemic is mostly over (for awhile, now), they can't even get 1/month entered in the TIGRIS trial!. They've chosen the wrong hospitals? Someone interfering in assessing new entrants? Maybe Baxter wants to slow it down so that they can take this over for a song??!! They make it sound like it's the cat's meow but is it all bark on no bite?
BRUTAL long process!
You get a sniff of goo fortune into the .50's and then back to the .30's. Has there been any other trials that have taken so long, to get 40% through????


 

<< Previous
Bullboard Posts
Next >>